Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05102786 · ClinicalTrials.gov registry record
CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
A clinical trial, sponsored by RAI Services Company.
- Completed
- Registry status
- 1,180
- Enrollment target
NCT05102786: Completed study, sponsored by RAI Services Company.
NCT05102786 is a clinical trial that has completed, run by RAI Services Company. The registered enrollment target is 1,180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05102786 has completed, sponsored by RAI Services Company.
- COMPLETED
- Registry status
- 1,180 participants
- Enrollment target
Study Summary
This is a multi-site, open-label, 8-week, prospective observational study, conducted at multiple sites geographically dispersed within the U.S. The purpose of this Actual Use Study (AUS) is to investigate how U.S. adult tobacco consumers 21 to 60 years of age, inclusive, who typically smoke on average (≥5 cigarettes/day) on at least 20 out of the past 30 days will use a heated tobacco product comprising a heating device and four non-combusted cigarette variants (HTP Investigational Product \[IP\]) over a 6-week Actual Use Period (AUP) in their real-life/naturalistic environment and in the context of typical consumer marketing materials.
Primary Outcome
Number and proportion of subjects who meet the definition of "established users" of the HTP IP
Interventions
- OTHER 40007388
- OTHER 40007385
- OTHER 40007387
- OTHER 40007386
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,180 participants |
| Start Date | 2021-10-26 |
| Est. Completion | 2022-03-08 |
What the finished NCT05102786 record still lists
NCT05102786 is an observational study that tracks outcomes without assigning an intervention. Its 1,180 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 4 interventions - of which 40007388 is the first listed.
NCT05102786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05102786 about?
NCT05102786 is a clinical study titled "CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers". This is a multi-site, open-label, 8-week, prospective observational study, conducted at multiple sites geographically dispersed within the U.S. The purpose of this Actual Use Study (AUS) is to investigate how U.S. adult tobacco consumers 21 to 60 years of age, inclusive, who typically smoke on avera...
What is the current status of trial NCT05102786?
This trial is currently completed. The enrollment target is 1,180 participants. The study started on 2021-10-26. Estimated completion is 2022-03-08.
What interventions are being tested in trial NCT05102786?
The interventions under investigation include: 40007388 (OTHER), 40007385 (OTHER), 40007387 (OTHER), 40007386 (OTHER).
Who is sponsoring clinical trial NCT05102786?
This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07286058 · 1,182 participants · Phase 3
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- NCT05688436 · 1,178 participants
A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babies
- NCT06931275 · 1,178 participants · NA
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI